Screener
Pacific Biosciences of California PACB Business Segments — G&A
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001299130-26-000122
| (In thousands) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of revenue | 26,369 | 25,082 | 50,706 | 63,606 |
| Research and development | 23,022 | 22,529 | 42,630 | 51,582 |
| Sales and marketing | 18,492 | 19,516 | 34,270 | 39,592 |
| General and administrative | 14,901 | 16,659 | 30,276 | 36,751 |
| Impairment charges | — | — | — | 15,000 |
| Settlement charges | — | — | 15,400 | — |
| Gain on disposal of assets | — | — | (45,796) | — |
| Change in fair value of contingent consideration | — | — | — | (18,700) |
Item 1. Financial Statements (unaudited):
FAQ
- What is Pacific Biosciences of California's business segments — G&A?
- Pacific Biosciences of California (PACB) reported business segments — G&A of $14.9M in Q2 2026.
- How has Pacific Biosciences of California's business segments — G&A changed year-over-year?
- Pacific Biosciences of California's business segments — G&A decreased by 10.6% year-over-year, from $16.66M to $14.9M.
- What is the long-term trend for Pacific Biosciences of California's business segments — G&A?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's business segments — G&A has grown at a -3.6% compound annual growth rate (CAGR), from $76.39M to $68.52M.
- What does business segments — G&A mean?
- These are the overhead costs associated with the management, legal, human resources, and finance functions required to support the segment's operations. It is a key metric for evaluating the company's operational leverage and the scalability of its corporate infrastructure.
Ask your AI about Pacific Biosciences of California's business segments — g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude